Preoperative Estimated Risk of Microvascular Invasion is Associated with Prognostic Differences Following Liver Resection Versus Radiofrequency Ablation for Early Hepatitis B Virus-Related Hepatocellular Carcinoma

2021 ◽  
Author(s):  
Shilei Bai ◽  
Pinghua Yang ◽  
Zhihao Xie ◽  
Jun Li ◽  
Zhengqing Lei ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Hepatitis B Virus ◽  
Liver Resection ◽  
Hepatitis B ◽  
Microvascular Invasion ◽  
B Virus ◽  
Estimated Risk

scholarly journals Nucleos(t)ide analogues and Hepatitis B virus-related hepatocellular carcinoma: A literature review

2020 ◽  
Vol 28 ◽  
pp. 204020662092133 ◽  
Author(s):  
Mohamed A Abd El Aziz ◽  
Rodolfo Sacco ◽  
Antonio Facciorusso
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Hepatitis B Virus ◽  
Hepatitis B ◽  
Literature Review ◽  
Nucleoside Analogues ◽  
B Virus ◽  
Effect Of Treatment ◽  
Related Mortality

Hepatitis B virus is mainly considered to cause hepatocellular carcinoma which is the fourth leading cause of cancer-related mortality worldwide. Treatment of Hepatitis B virus with nucleos(t)ide analogues can decrease the progression of the disease and subsequently decreases the incidence of hepatocellular carcinoma. In this review, we have discussed the different classes of nucleos(t)ide analogues used in the treatment of Hepatitis B virus and their relationship with the development of hepatocellular carcinoma. Furthermore, we discussed the effect of treatment of Hepatitis B virus with Nucleoside analogues (NAs) before, during and after surgery, chemoembolization, radiofrequency ablation, and chemotherapy for the treatment of hepatocellular carcinoma.

Sign in / Sign up

Export Citation Format

Share Document